Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel carbene catalysis enables efficient production of chiral dihydrocoumarin derivatives with dual chiral centers, offering significant supply chain stability.
Patent CN115340572B discloses X-Binaphane, a novel xanthene-based bisphosphine ligand enabling high stereoselectivity in API manufacturing with scalable synthesis.
Novel two-step route using bis-ketal glucose enables high-purity chiral monomers for reusable polymer-supported asymmetric catalysis applications.
Novel synthesis route for Efavirenz chiral ligand from L-Alanine. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN113999201B details chiral asymmetric synthesis for high-purity nicotine. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN103012498A reveals high-efficiency Ir-catalysts for ketone reduction, offering scalable routes for chiral pharmaceutical intermediates.
Discover advanced chiral pyridoxal catalysts for asymmetric aldol reactions. Enable cost reduction in fine chemical manufacturing with scalable, metal-free synthesis routes.
Novel (R)-ω-transaminase mutant enables high-conversion synthesis of Sitagliptin intermediates, offering cost-effective and scalable pharmaceutical manufacturing solutions.
Patent CN112624962A reveals novel double-chiral carbazolyl isopropanolamines with potent bactericidal activity, offering scalable routes for agrochemical manufacturing.
Novel one-step route to 4-fluorobenzoic acid-(R)-phenylethylamine salt using Cu-catalyst. Offers simplified processing for high-purity chiral intermediates.
Patent CN1844110B details a novel acidic deprotection route for Valsartan intermediates, ensuring >99% ee and eliminating toxic reagents for reliable supply.
Patent CN113754694B reveals a novel chiral bicyclic imidazole catalyst method for Remdesivir. Achieve high-purity API intermediates with reduced manufacturing costs.
Patent CN1882600A reveals a novel route for enantiomerically enriched bisphospholane ligands, offering significant cost reduction in pharmaceutical intermediate manufacturing and improved supply chain reliability.
Patent CN103373948A details a high-yield 6-step asymmetric synthesis of (-)-Kainic Acid using Rh-catalysis, offering a reliable alternative to natural extraction for neuroscience research.
Patent CN120897923A introduces stable ligand synthesis eliminating hazardous solvents. Achieve cost reduction in pharmaceutical intermediates manufacturing with enhanced supply chain reliability.
Patent CN105061417A reveals a novel asymmetric trifunctional monomer offering superior heat resistance and processability for electronic chemical manufacturing and advanced composites.
Novel one-pot method for esomeprazole magnesium reduces steps and enhances purity. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Novel synthesis of Ottensinin from Sclareolide. Reduced steps, mild conditions. Reliable supplier for pharmaceutical intermediates. Cost effective production.
Novel synthesis route for Saxagliptin intermediate CN105037245B. High yield, scalable process for reliable pharmaceutical intermediate supply chain optimization.
Patent CN102382138B details a robust two-step synthesis for chiral phosphoramides. Discover cost-effective manufacturing routes for asymmetric catalysis intermediates.